Neurobehavioral Disorders

Latest News

Methylphenidate Beneficial in ADHD After 2 or More Years

Current guidelines include recommendations on how to prescribe methylphenidate, but lack of recommendations regarding the long-term use of the drug.

Does Montelukast Increase the Risk for Neuropsychiatric Disease?

In both cohorts, the risk for neuropsychiatric disease increased in children with poorly controlled asthma.

TMS Device Cleared to Treat Obsessive Compulsive Disorder

Transcranial magnetic stimulation (TMS) uses magnetic fields to stimulate nerve cells in the brain.

Methylphenidate Good First-Choice Pediatric ADHD Drug

Methylphenidate should be considered as a first choice for the treatment of ADHD in children and adolescents.

High Frequency of Digital Media Use Linked to ADHD Symptoms

There is a modest, but statistically significant, association between higher frequency of digital media use and subsequent symptoms of ADHD among adolescents.

Increase in Pediatric ADHD Meds Exposures from 2000 to 2011

From 2000 through 2011 there was an increase in pediatric ADHD medication exposures reported to US poison control centers.

Trintellix Labeling Updated With Data on Improved Processing Speed in MDD

Lundbeck announced that the FDA has approved a sNDA for Trintellix to include data regarding improved processing speed.

Anomalous Brain Structure ID’d in Preschoolers With ADHD

Reductions in bilateral frontal, parietal, and temporal lobe gray matter volumes found in ADHD.

Neural Markers of Depression Resilience ID’d in Female Teens

Adolescent females at high familial risk of depression who do not go on to develop depression have compensatory functional connectivity patterns in emotion regulatory networks.

PTSD Symptoms May Benefit From Closed-Loop Neurotechnology

Use of HIRREM, a closed-loop, allostatic, acoustic, stimulation neurotechnology can reduce PTSD symptoms, insomnia and depression in veterans.